Cargando…

Interaction Interface of Aβ(42) with Human Na,K-ATPase Studied by MD and ITC and Inhibitor Screening by MD

Alzheimer’s disease (AD) is a neurodegenerative disease accompanied by progressive cognitive and memory dysfunction due to disruption of normal electrotonic properties of neurons and neuronal loss. The Na,K-ATPase interaction with beta amyloid (Aβ) plays an important role in AD pathogenesis. It has...

Descripción completa

Detalles Bibliográficos
Autores principales: Adzhubei, Alexei A., Tolstova, Anna P., Strelkova, Maria A., Mitkevich, Vladimir A., Petrushanko, Irina Yu., Makarov, Alexander A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313104/
https://www.ncbi.nlm.nih.gov/pubmed/35884966
http://dx.doi.org/10.3390/biomedicines10071663
_version_ 1784753997278609408
author Adzhubei, Alexei A.
Tolstova, Anna P.
Strelkova, Maria A.
Mitkevich, Vladimir A.
Petrushanko, Irina Yu.
Makarov, Alexander A.
author_facet Adzhubei, Alexei A.
Tolstova, Anna P.
Strelkova, Maria A.
Mitkevich, Vladimir A.
Petrushanko, Irina Yu.
Makarov, Alexander A.
author_sort Adzhubei, Alexei A.
collection PubMed
description Alzheimer’s disease (AD) is a neurodegenerative disease accompanied by progressive cognitive and memory dysfunction due to disruption of normal electrotonic properties of neurons and neuronal loss. The Na,K-ATPase interaction with beta amyloid (Aβ) plays an important role in AD pathogenesis. It has been shown that Na,K-ATPase activity in the AD brain was significantly lower than those in age-matched control brain. The interaction of Aβ(42) with Na,K-ATPase and subsequent oligomerization leads to inhibition of the enzyme activity. In this study interaction interfaces between three common Aβ(42) isoforms, and different conformations of human Na,K-ATPase (α1β1) have been obtained using molecular modeling, including docking and molecular dynamics (MD). Interaction sites of Na,K-ATPase with Aβ(42) are localized between extracellular parts of α- and β- subunits and are practically identical for Na,K-ATPase at different conformations. Thermodynamic parameters for the formation of Na,K-ATPase:Aβ(42) complex at different conformations acquired by isothermal titration calorimetry (ITC) are similar, which is in line with the data of molecular modeling. Similarity of Na,K-ATPase interaction interfaces with Aβ in all conformations allowed us to cross-screen potential inhibitors for this interaction and find pharmaceutical compounds that could block it.
format Online
Article
Text
id pubmed-9313104
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93131042022-07-26 Interaction Interface of Aβ(42) with Human Na,K-ATPase Studied by MD and ITC and Inhibitor Screening by MD Adzhubei, Alexei A. Tolstova, Anna P. Strelkova, Maria A. Mitkevich, Vladimir A. Petrushanko, Irina Yu. Makarov, Alexander A. Biomedicines Article Alzheimer’s disease (AD) is a neurodegenerative disease accompanied by progressive cognitive and memory dysfunction due to disruption of normal electrotonic properties of neurons and neuronal loss. The Na,K-ATPase interaction with beta amyloid (Aβ) plays an important role in AD pathogenesis. It has been shown that Na,K-ATPase activity in the AD brain was significantly lower than those in age-matched control brain. The interaction of Aβ(42) with Na,K-ATPase and subsequent oligomerization leads to inhibition of the enzyme activity. In this study interaction interfaces between three common Aβ(42) isoforms, and different conformations of human Na,K-ATPase (α1β1) have been obtained using molecular modeling, including docking and molecular dynamics (MD). Interaction sites of Na,K-ATPase with Aβ(42) are localized between extracellular parts of α- and β- subunits and are practically identical for Na,K-ATPase at different conformations. Thermodynamic parameters for the formation of Na,K-ATPase:Aβ(42) complex at different conformations acquired by isothermal titration calorimetry (ITC) are similar, which is in line with the data of molecular modeling. Similarity of Na,K-ATPase interaction interfaces with Aβ in all conformations allowed us to cross-screen potential inhibitors for this interaction and find pharmaceutical compounds that could block it. MDPI 2022-07-11 /pmc/articles/PMC9313104/ /pubmed/35884966 http://dx.doi.org/10.3390/biomedicines10071663 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Adzhubei, Alexei A.
Tolstova, Anna P.
Strelkova, Maria A.
Mitkevich, Vladimir A.
Petrushanko, Irina Yu.
Makarov, Alexander A.
Interaction Interface of Aβ(42) with Human Na,K-ATPase Studied by MD and ITC and Inhibitor Screening by MD
title Interaction Interface of Aβ(42) with Human Na,K-ATPase Studied by MD and ITC and Inhibitor Screening by MD
title_full Interaction Interface of Aβ(42) with Human Na,K-ATPase Studied by MD and ITC and Inhibitor Screening by MD
title_fullStr Interaction Interface of Aβ(42) with Human Na,K-ATPase Studied by MD and ITC and Inhibitor Screening by MD
title_full_unstemmed Interaction Interface of Aβ(42) with Human Na,K-ATPase Studied by MD and ITC and Inhibitor Screening by MD
title_short Interaction Interface of Aβ(42) with Human Na,K-ATPase Studied by MD and ITC and Inhibitor Screening by MD
title_sort interaction interface of aβ(42) with human na,k-atpase studied by md and itc and inhibitor screening by md
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313104/
https://www.ncbi.nlm.nih.gov/pubmed/35884966
http://dx.doi.org/10.3390/biomedicines10071663
work_keys_str_mv AT adzhubeialexeia interactioninterfaceofab42withhumannakatpasestudiedbymdanditcandinhibitorscreeningbymd
AT tolstovaannap interactioninterfaceofab42withhumannakatpasestudiedbymdanditcandinhibitorscreeningbymd
AT strelkovamariaa interactioninterfaceofab42withhumannakatpasestudiedbymdanditcandinhibitorscreeningbymd
AT mitkevichvladimira interactioninterfaceofab42withhumannakatpasestudiedbymdanditcandinhibitorscreeningbymd
AT petrushankoirinayu interactioninterfaceofab42withhumannakatpasestudiedbymdanditcandinhibitorscreeningbymd
AT makarovalexandera interactioninterfaceofab42withhumannakatpasestudiedbymdanditcandinhibitorscreeningbymd